Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
06.03. | Amid patent fight, Sandoz biosimilars to Amgen bone blockbusters gain FDA nods | ||
06.03. | Merz adds another star to its galaxy of Xeomin partners, tapping Demi Lovato to push Botox rival | ||
06.03. | DVT Awareness Month sparks push to counter clots with education | ||
06.03. | AbbVie leads DTC spend once again as overall spending drops like a stone in February | ||
05.03. | GSK rewards CEO Walmsley with 51% pay hike after beating sales, profit goals | ||
05.03. | Vanda's jet-lag approval hopes for Hetlioz quashed with FDA hearing rejection | ||
05.03. | Telix spends up to $82M to boost isotope production with ARTMS buyout | ||
05.03. | Incyte turns to generative AI to illustrate the 'unseen journey' of living with MPN | ||
05.03. | Novo Nordisk's success with Ozempic in diabetes and kidney disease patients isn't enough for investors | ||
05.03. | After Formosa snags FDA nod for reformulation of old steroid, partner Eyenovia plots launch | ||
05.03. | Warren rebukes GSK for alleged 'money grab' after company pulled popular asthma med | ||
05.03. | Bayer CEO launches 'full-scale effort' to rejuvenate pharma pipeline, tables split-up but warns not never | ||
05.03. | Jane Seymour backs Insmed's push to tackle gender and age biases | ||
04.03. | As Medicare price negotiations roll on, drugmakers counter HHS' initial offers | ||
04.03. | Pfizer stops buildout of $350M Seagen plant, leaving 120 workers' roles in question | ||
04.03. | RSV vaccines may raise risk of Guillain-Barré syndrome, FDA preliminary analysis finds | ||
04.03. | With Takeda out of the picture, J&J's Rybrevant moves into first line in lung cancer subtype | ||
04.03. | Perrigo's over-the-counter birth control launch takes flight in the US | ||
04.03. | After multiple wrist-slaps, Aurobindo unit Eugia receives another manufacturing write-up | ||
04.03. | Guardant Health exposes colorectal cancer screening gap with new Harris Poll report | ||
04.03. | American Cancer Society, Colorectal Cancer Alliance team up for 'Your Colon is 45' campaign | ||
04.03. | Teva slammed for breaching drug promotion code in earned media article | ||
01.03. | After PhRMA loss, AstraZeneca's challenge to IRA price negotiations is rejected | ||
01.03. | Moderna lays off parts of manufacturing team after resizing COVID footprint | ||
01.03. | Ahead of strategy reveal, Bayer taps activist investor Jeffrey Ubben for board seat |